Related Experiment Videos

Left ventricular mass and geometry in patients with established hypertension and white coat hypertension

A Høegholm1, K S Kristensen, L E Bang

  • 1Department of Internal Medicine, County Central Hospital, Naestved, Denmark.

Insights

White coat hypertension patients show less cardiac hypertrophy than established hypertension patients. Ambulatory blood pressure, not office readings, predicts cardiac changes, suggesting white coat hypertension may not require drug treatment.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Medicine

Background:

  • White coat hypertension (WCH) is characterized by elevated office blood pressure but normal out-of-office readings.
  • Established hypertension (EH) involves consistently high blood pressure readings.
  • Cardiac involvement, such as left ventricular hypertrophy, is a known complication of hypertension.

Purpose of the Study:

  • To compare cardiac mass and geometry in patients with WCH versus EH.
  • To determine the association between blood pressure measurement methods (office vs. ambulatory) and cardiac structural changes.
  • To evaluate the clinical implications for treatment decisions in WCH.

Main Methods:

  • Prospective study of 143 newly diagnosed hypertensive patients.
  • Comparison of office blood pressure, 24-hour ambulatory blood pressure monitoring (ABPM), and echocardiography.
  • Patients categorized into WCH (n=53) and EH (n=90) based on ABPM.

Main Results:

  • Left ventricular mass index (LVMI) and relative wall thickness (RWT) were significantly higher in EH patients compared to WCH patients.
  • Ambulatory blood pressure measurements, not office readings, were significantly associated with cardiac hypertrophy.
  • A higher proportion of WCH patients (83%) had normal left ventricular dimensions compared to EH patients (61%).

Conclusions:

  • White coat hypertensive patients exhibit less cardiac structural alteration than those with established hypertension.
  • Ambulatory blood pressure monitoring is a better predictor of cardiac hypertrophy than office blood pressure measurements.
  • WCH patients may be managed as normotensives, potentially avoiding pharmacological antihypertensive therapy.

Related Concept Videos